Concord Biotech Ltd Q1 FY2024-2025 Results: Summary
Revenue | ₹227.46Cr |
Net Profits | ₹59.59Cr |
Net Profit Margins | 26.20% |
Highlights
Revenue:
Concord Biotech Ltd’s revenue jumped 9.61% since last year same period to ₹227.46Cr in the Q1 2024-2025. On a quarterly growth basis, Concord Biotech Ltd has generated -31.03% fall in its revenue since last 3-months.
Net Profits:
Concord Biotech Ltd’s net profit jumped 9.36% since last year same period to ₹59.59Cr in the Q1 2024-2025. On a quarterly growth basis, Concord Biotech Ltd has generated -37.29% fall in its net profits since last 3-months.
Net Profit Margins:
Concord Biotech Ltd’s net profit margin fell -0.23% since last year same period to 26.20% in the Q1 2024-2025. On a quarterly growth basis, Concord Biotech Ltd has generated -9.08% fall in its net profit margins since last 3-months.
